Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Myelodysplastic Syndromes 62Hodgkin Disease 57Leukemia 56Leukemia, Lymphocytic, Chronic, B-Cell 55Multiple Myeloma 51Lymphoma, Non-Hodgkin 48Lymphoma 44Myeloproliferative Disorders 37Graft vs Host Disease 37Lymphoma, Follicular 36Congenital Abnormalities 36Lymphoma, Large B-Cell, Diffuse 35Leukemia, Myeloid, Accelerated Phase 35Lymphoma, Mantle-Cell 34Lymphoma, B-Cell, Marginal Zone 31Leukemia, Myeloid, Chronic-Phase 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Hematologic Neoplasms 29Burkitt Lymphoma 28Leukemia, Myelomonocytic, Chronic 27Blast Crisis 27Primary Myelofibrosis 26Neoplasms, Plasma Cell 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Waldenstrom Macroglobulinemia 17Lymphoma, T-Cell, Cutaneous 16Anemia, Refractory, with Excess of Blasts 16

Interventions

aldesleukin 9Interleukin-2 9Nivolumab 7fludarabine phosphate 6Dacarbazine 6Cyclophosphamide 6fludarabine 5Temozolomide 4Ipilimumab 4Fluorouracil 4montanide ISA 51 3Surveys and Questionnaires 3Semaxinib 3Radiotherapy 3Radiation 3Mohs Surgery 3Educational Status 3Cisplatin 3Allovectin-7 3zanolimumab 2talabostat 2sonidegib 2poly ICLC 2binimetinib 2Whole-Body Irradiation 2Vinblastine 2Vemurafenib 2Tacrolimus 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Skin Neoplasms × Tacrolimus × Clear all
NCT00133887 2025-12-26

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Hospices Civils de Lyon

Phase 3 Completed
77 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

NCT00129961 2012-04-11

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 4 Completed
86 enrolled 22 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡